Lacosamid Genericon (Lacosamide)

• Lacosamide is an antiepileptic medication that acts on focal seizure activity.
• Partial-onset seizures: Used as adjunctive therapy to reduce seizure frequency in patients with focal seizures.
• Focal seizures with secondary generalization: Helps control seizures that spread from a focal origin to involve both hemispheres.
• Epilepsy adjunctive treatment: Provides additional seizure control when first‑line antiepileptic drugs are insufficient.

• Lacosamide enhances the slow inactivation of voltage‑gated sodium channels in neuronal membranes, stabilizing hyper‑excitable neuronal tissue and reducing repetitive firing that can trigger seizures. This selective modulation of sodium channel activity contributes to its antiepileptic effect without significantly affecting fast inactivation processes.

Lacosamide may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Dizziness: Sensation of light‑headedness or imbalance.
• Headache: Mild to moderate head pain.
• Nausea: Stomach discomfort often accompanied by urge to vomit.
• Fatigue: Unusual tiredness or lack of energy.
• Diplopia: Double vision, especially at higher doses.
• Somnolence: Increased sleepiness during the day.

Serious or Rare Side Effects

• Cardiac conduction abnormalities: PR‑interval prolongation or atrial fibrillation.
• Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Suicidal ideation: Emergence of thoughts of self‑harm.
• Hepatic dysfunction: Elevated liver enzymes or hepatitis.
• Hypersensitivity reactions: Rash, swelling, or anaphylaxis.
• Mood changes: Depression or anxiety worsening.

When prescribing Lacosamid Genericon, clinicians should consider several safety aspects.

• Renal impairment: Adjust dosage and monitor renal function.
• Hepatic impairment: Monitor liver enzymes and consider dose modification.
• Cardiac conduction disorders: Perform baseline ECG and monitor for arrhythmias.
• Pregnancy: Potential risks are unknown; discuss benefits versus risks with the patient.
• Concomitant CNS depressants: Observe for enhanced sedation or respiratory depression.
• Store at ambient temperature: Keep below 25 °C in the original packaging, protect from moisture and light.

Lacosamide can interact with other medicines, requiring careful management.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., ketoconazole): May increase lacosamide plasma levels.
• Co‑administration with other sodium‑channel blockers (e.g., carbamazepine): Heightens risk of cardiac conduction effects.

Moderate Interactions (Monitor Closely)

• CYP3A4 inducers (e.g., rifampin): May reduce lacosamide effectiveness.
• Other antiepileptic drugs: Potential additive effects on seizure control.
• Alcohol: May intensify central nervous system depression.
• Anticoagulants: Monitor for altered bleeding risk.